Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Efficacy and safety of duloxetine 60 mg once daily in major depressive disorder: a review with expert commentary.

Ball SG, Desaiah D, Zhang Q, Thase ME, Perahia DG.

Drugs Context. 2013 Jan 3;2013:212245. doi: 10.7573/dic.212245. eCollection 2013 Jan 3. Review.

2.

Anxiety but not social stressors predict 12-month depression and pain severity.

Bair MJ, Poleshuck EL, Wu J, Krebs EK, Damush TM, Tu W, Kroenke K.

Clin J Pain. 2013 Feb;29(2):95-101. doi: 10.1097/AJP.0b013e3182652ee9.

3.

Do early changes in the HAM-D-17 anxiety/somatization factor items affect the treatment outcome among depressed outpatients? Comparison of two controlled trials of St John's wort (Hypericum perforatum) versus a SSRI.

Bitran S, Farabaugh AH, Ameral VE, LaRocca RA, Clain AJ, Fava M, Mischoulon D.

Int Clin Psychopharmacol. 2011 Jul;26(4):206-12. doi: 10.1097/YIC.0b013e328343ba08.

4.

Efficacy and tolerability of duloxetine treatment in elderly patients with major depressive disorder and concurrent anxiety symptoms.

Russell J, Raskin J, Wiltse C, Walker D, Brawman-Mintzer O.

Psychiatry (Edgmont). 2007 Jun;4(6):33-45.

5.

Strategies to enhance the therapeutic efficacy of antidepressants: targeting residual symptoms.

Kurian BT, Greer TL, Trivedi MH.

Expert Rev Neurother. 2009 Jul;9(7):975-84. doi: 10.1586/ern.09.53. Review.

6.

Duloxetine in the treatment of generalized anxiety disorder.

Norman TR, Olver JS.

Neuropsychiatr Dis Treat. 2008 Dec;4(6):1169-80.

7.

Duloxetine in the treatment of major depressive disorder.

Goldstein DJ.

Neuropsychiatr Dis Treat. 2007 Apr;3(2):193-209.

8.

The role of duloxetine in the treatment of anxiety disorders.

De Berardis D, Serroni N, Carano A, Scali M, Valchera A, Campanella D, D'Albenzio A, Di Giuseppe B, Moschetta FS, Salerno RM, Ferro FM.

Neuropsychiatr Dis Treat. 2008 Oct;4(5):929-35.

9.

Association of depression and anxiety alone and in combination with chronic musculoskeletal pain in primary care patients.

Bair MJ, Wu J, Damush TM, Sutherland JM, Kroenke K.

Psychosom Med. 2008 Oct;70(8):890-7. doi: 10.1097/PSY.0b013e318185c510. Epub 2008 Sep 16.

10.

Efficacy of duloxetine for the treatment of generalized anxiety disorder: implications for primary care physicians.

Koponen H, Allgulander C, Erickson J, Dunayevich E, Pritchett Y, Detke MJ, Ball SG, Russell JM.

Prim Care Companion J Clin Psychiatry. 2007;9(2):100-7.

11.

Recognizing and Treating the Physical Symptoms of Depression in Primary Care.

[No authors listed]

Prim Care Companion J Clin Psychiatry. 2004;6(4):168-177.

Supplemental Content

Support Center